Welcome Guest!  Login | Register | Help
Home News Screener Maps Groups Portfolio Insider Futures Forex Collaborate Store Elite
Order: Signal: Tickers:
Overview Valuation Financial Ownership Performance Technical Custom Charts Tickers Quotes Basic TA News Snapshot
Total: 1 #1
TickerAZN [NYSE]
CompanyAstraZeneca PLC
CountryUnited Kingdom
IndustryDrug Manufacturers - Major
Market Cap93.90BEPS (ttm)1.61
P/E46.06EPS this Y-58.70%
Forward P/E18.19EPS next Y-7.17%
PEG76.77EPS past 5Y-13.40%
P/S3.62EPS next 5Y0.60%
P/B4.25EPS Q/Q-4.50%
Dividend5.12%Sales Q/Q3.60%
Insider Own-Inst Own7.90%
Insider Trans-Inst Trans-18.07%
Short Float0.17%EarningsJan 27/b
Analyst Recom3.00Target Price76.59
Avg Volume2.25M52W Range48.24 - 82.68
18-Sep-14 04:52PMFDA Approves Lilly's Once-Weekly Shot For Diabetes at Forbes
17-Sep-14 06:15PMIsis Pharmaceuticals CEO: Not changing name, terrorists c... CNBC
17-Sep-14 03:45PMAstraZeneca's Constipation Drug Movantik Gets FDA Nod Zacks
16-Sep-14 04:20PMAstraZeneca and Eli Lilly Collaborate for Alzheimer's Drug Zacks
16-Sep-14 02:12PMAlzheimer's drug fight CNBC
16-Sep-14 02:02PMNektar says FDA clears constipation drug Movantik AP
16-Sep-14 01:58PMFDA Approves MOVANTIK (naloxegol) Tablets C-II for the Treatment of Opioid-Induced Constipation in Adult Patients with Chronic Non-Cancer Pain Business Wire
16-Sep-14 01:31PMPharma in focus: Ebola & Enterovirus D68 CNBC
16-Sep-14 12:36PMHow Will AstraZeneca (AZN) Stock React to FDA's Movantik Approval? at TheStreet
16-Sep-14 07:17AMEli Lilly agrees to co-develop AstraZeneca's Alzheimer's treatment at MarketWatch